SYNTHO 230 (Esterified estrogens and methyltestosterone 0.625 mg / 1.25 mg)
Pill imprint SYNTHO 230 has been identified as Esterified estrogens and methyltestosterone 0.625 mg / 1.25 mg.
Esterified estrogens/methyltestosterone is used in the treatment of menopausal disorders; postmenopausal symptoms; hot flashes and belongs to the drug class sex hormone combinations. Not for use in pregnancy. Esterified estrogens/methyltestosterone 0.625 mg / 1.25 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- SYNTHO 230
- Strength:
- 0.625 mg / 1.25 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Sex hormone combinations
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- 3 - Moderate abuse potential
- Manufacturer:
- Syntho Pharmaceuticals Inc.
- National Drug Code (NDC):
- 50220-0001
- Inactive Ingredients:
- lactose
magnesium stearate
microcrystalline cellulose
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 15310-0020 | Creekwood Pharmaceutical Inc |
Note: Inactive ingredients may vary.
More about esterified estrogens/methyltestosterone
Consumer resources
- Esterified estrogens/methyltestosterone
- Esterified estrogens and methyltestosterone
- Esterified estrogens and methyltestosterone (Advanced Reading)
- Other brands: Estratest, Covaryx, EEMT HS, Covaryx HS, More (6) »
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
